Vercesi, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia
Abbreviations: DBPC, double-blind placebo-controlled
When the gut barrier breaks down, bacterial endotoxins and food-derived antigens enter the bloodstream
Solutions should be visually inspected for particulate matter and discoloration prior to administration, and containers exhibiting haze, precipitate, or seal compromise must be discarded
2 For instance, non-recommended dose-reduced DOAC therapy was reported in 23.2% (2,423/10,426) of patients with AFib in the GARFIELD-AF registry.23 In the RIETE registry, among 4,716 patients receiving DOACs for acute VTE, 475 (10.1%) received a lower-than-recommended dose for acute treatment